AptaBio Therapeutics Inc. (KOSDAQ:293780)
8,250.00
-30.00 (-0.36%)
Aug 13, 2025, 3:30 PM KST
Accolade Revenue
AptaBio Therapeutics had revenue of 382.70M KRW in the quarter ending March 31, 2025, a decrease of -39.94%. This brings the company's revenue in the last twelve months to 3.11B, up 229.91% year-over-year. In the year 2024, AptaBio Therapeutics had annual revenue of 3.36B with 937.76% growth.
Revenue (ttm)
3.11B
Revenue Growth
+229.91%
P/S Ratio
71.39
Revenue / Employee
n/a
Employees
n/a
Market Cap
221.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.36B | 3.04B | 937.76% |
Dec 31, 2023 | 323.87M | 275.52M | 569.80% |
Dec 31, 2022 | 48.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition